Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVAMP: Everolimus for Advanced Malignancies in Peutz-Jeghers Syndrome
NCT01178151Phase 2Withdrawn
- Sponsor
- University of Amsterdam
- Start
- Oct 2010
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in Peutz-Jeghers syndrome (PJS), metastatic neoplasm, Neoplasm, sponsored by University of Amsterdam. Planned start Oct 2010; status: withdrawn.
02
Drugs
everolimus
03
Conditions
Peutz-Jeghers syndrome (PJS)metastatic neoplasmNeoplasm
Beyond the preview
Go deeper on NCT01178151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01178151.